AngioDynamics Toekomstige groei
Future criteriumcontroles 0/6
Belangrijke informatie
95.2%
Groei van de winst
95.5%
Groei van de winst per aandeel
Medical Equipment winstgroei | 17.4% |
Inkomstengroei | 7.1% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 04 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Jul 19Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified
Jul 18AngioDynamics: A Story To Monitor
May 14A Leaner AngioDynamics Is A High-Risk Execution-Driven Story
Apr 09AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry
Apr 06AngioDynamics: Restructuring Initiative May Not Go Far Enough
Jan 14AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Oct 12AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt
Mar 31AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance
Oct 06AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold
Sep 29Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?
Sep 02AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M
Jul 12Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
5/31/2027 | 343 | -2 | N/A | N/A | 1 |
5/31/2026 | 306 | -28 | N/A | N/A | 3 |
5/31/2025 | 284 | -39 | N/A | N/A | 3 |
8/31/2024 | 293 | -243 | -27 | -21 | N/A |
5/31/2024 | 304 | -184 | -34 | -28 | N/A |
2/29/2024 | 324 | -192 | -23 | -17 | N/A |
11/30/2023 | 330 | -14 | -7 | -3 | N/A |
8/31/2023 | 336 | 6 | -5 | -1 | N/A |
5/31/2023 | 339 | -52 | -4 | 0 | N/A |
2/28/2023 | 335 | -37 | -12 | -7 | N/A |
11/30/2022 | 328 | -33 | -22 | -17 | N/A |
8/31/2022 | 321 | -33 | -28 | -23 | N/A |
5/31/2022 | 316 | -27 | -11 | -7 | N/A |
2/28/2022 | 306 | -40 | -7 | -4 | N/A |
11/30/2021 | 303 | -38 | 7 | 11 | N/A |
8/31/2021 | 298 | -34 | 16 | 21 | N/A |
5/31/2021 | 291 | -32 | 19 | 24 | N/A |
2/28/2021 | 273 | -169 | 10 | 16 | N/A |
11/30/2020 | 271 | -171 | -14 | -8 | N/A |
8/31/2020 | 268 | -170 | -21 | -13 | N/A |
5/31/2020 | 264 | -167 | -22 | -15 | N/A |
2/29/2020 | 277 | -7 | 0 | 7 | N/A |
11/30/2019 | 273 | -6 | 27 | 33 | N/A |
8/31/2019 | 273 | -7 | 36 | 40 | N/A |
5/31/2019 | 271 | -11 | 34 | 37 | N/A |
2/28/2019 | 205 | -34 | 33 | 36 | N/A |
11/30/2018 | 223 | -16 | 28 | 32 | N/A |
8/31/2018 | 240 | -12 | 26 | 29 | N/A |
5/31/2018 | 262 | -6 | N/A | 41 | N/A |
2/28/2018 | 343 | 1 | N/A | 37 | N/A |
11/30/2017 | 345 | -10 | N/A | 47 | N/A |
8/31/2017 | 347 | 4 | N/A | 51 | N/A |
5/31/2017 | 270 | -7 | N/A | 56 | N/A |
2/28/2017 | 356 | -25 | N/A | 55 | N/A |
11/30/2016 | 358 | -27 | N/A | 53 | N/A |
8/31/2016 | 357 | -42 | N/A | 48 | N/A |
5/31/2016 | 351 | -44 | N/A | 45 | N/A |
2/29/2016 | 347 | -1 | N/A | 37 | N/A |
11/30/2015 | 346 | -6 | N/A | 37 | N/A |
8/31/2015 | 349 | -5 | N/A | 25 | N/A |
5/31/2015 | 352 | -3 | N/A | 26 | N/A |
2/28/2015 | 356 | -4 | N/A | 25 | N/A |
11/30/2014 | 358 | 5 | N/A | 12 | N/A |
8/31/2014 | 354 | 4 | N/A | 23 | N/A |
5/31/2014 | 351 | 2 | N/A | 25 | N/A |
2/28/2014 | 346 | 2 | N/A | 26 | N/A |
11/30/2013 | 340 | -3 | N/A | 37 | N/A |